Wespac Advisors So Cal, LLC Mannkind Corp Transaction History

Wespac Advisors So Cal, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 30, 2019	SELL	$1.09 - $1.88 $697 - $1,203	-640 Closed	0 $0
Q3 2018 Oct 22, 2018	BUY	$1.01 - $2.19 $646 - $1,401	640 New	640 $1,000
Q2 2018 Jul 13, 2018	SELL	$1.59 - $2.38 $1,017 - $1,523	-640 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	640	640 $0

210

130M

1.81M

808K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.32B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.